Luz Garcia-Valdes

Dr. Luz Garcia-Valdes

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2016 in BMC Public Health
Verified
Journal Article
Open access
PDF file
OTon behalf of the PREOBE team
on behalf of the PREOBE team
SBStaffan K Berglund
Staffan K Berglund
LGLuz Garcia-Valdes
Luz Garcia-Valdes
FTFrancisco J. Torres-Espínola
Francisco J. Torres-Espínola
MSMaria Teresa Segura
Maria Teresa Segura
Cristina CampoyCristina Campoy
Cristina Campoy
Maternal overweight, obesity, and gestational diabetes (GD) have been negatively associated with offspring development. Further knowledge regarding metabolic and nutritional alterations in these mother and their offspring are warranted. In an observational cohort study we included 331 pregnant women from Granada, Spain. The mothers were categorized into four groups according to BMI and their GD status; overweight (n:56), obese (n:64), GD (n:79), and healthy normal weight controls (n:132). We assessed maternal growth and nutritional biomarkers at 24 weeks (n = 269), 34 weeks (n = 310) and at delivery (n = 310) and the perinatal characteristics including cord blood biomarkers. Obese and GD mothers had significantly lower weight gain during pregnancy and infant birth weight, waist circumference, and placental weight were higher in the obese group, including a significantly increased prevalence of macrosomia. Except for differences in markers of glucose metabolism (glucose, HbA1c, insulin and uric acid) we found at some measures that overweight and/or obese mothers had lower levels of transferrin saturation, hemoglobin, Vitamin B12 and folate and higher levels of C-reactive protein, erythrocyte sedimentation rate, ferritin, and cortisol. GD mothers had similar differences in hemoglobin and C-reactive protein but higher levels of folate. The latter was seen also in cord blood. We identified several metabolic alterations in overweight, obese and GD mothers compared to controls. Together with the observed differences in infant anthropometrics, these may be important biomarkers in future research regarding the programming of health and disease in children. The trial was registered at clinicaltrials.gov, identifier ( NCT01634464 ).

9 September 2019 in Nutrients
Verified
Journal Article
Open access
PDF file
APAndrea de la Garza Puentes
Andrea de la Garza Puentes
AAAdrià Martí Alemany
Adrià Martí Alemany
ACAida Maribel Chisaguano
Aida Maribel Chisaguano
Rosa MontesRosa Montes
Rosa Montes
ABAna Isabel Bargalló
Ana Isabel Bargalló
MLM Carmen López-Sabater
M Carmen López-Sabater
This study analyzed how maternal obesity affected fatty acids (FAs) in breast milk and their association with infant growth and cognition to raise awareness about the programming effect of maternal health and to promote a healthy prenatal weight. Mother–child pairs (n = 78) were grouped per maternal pre-pregnancy body mass index (BMI): normal-weight (BMI = 18.5–24.99), overweight (BMI = 25–29.99) and obese (BMI > 30). Colostrum and mature milk FAs were determined. Infant anthropometry at 6, 18 and 36 months of age and cognition at 18 were analyzed. Mature milk exhibited lower arachidonic acid (AA) and docosahexaenoic acid (DHA), among others, than colostrum. Breast milk of non-normal weight mothers presented increased saturated FAs and n6:n3 ratio and decreased α-linolenic acid (ALA), DHA and monounsaturated FAs. Infant BMI-for-age at 6 months of age was inversely associated with colostrum n6 (e.g., AA) and n3 (e.g., DHA) FAs and positively associated with n6:n3 ratio. Depending on the maternal weight, infant cognition was positively influenced by breast milk linoleic acid, n6 PUFAs, ALA, DHA and n3 LC-PUFAs, and negatively affected by n6:n3 ratio. In conclusion, this study shows that maternal pre-pregnancy BMI can influence breast milk FAs and infant growth and cognition, endorsing the importance of a healthy weight in future generations.

17 August 2017 in Journal of Physiology and Biochemistry
Verified
Journal Article
Closed access
PDF file
TCTomás Cerdó
Tomás Cerdó
ARAlicia Ruiz
Alicia Ruiz
RJRuy Jáuregui
Ruy Jáuregui
HAHatim Azaryah
Hatim Azaryah
FTFrancisco José Torres-Espínola
Francisco José Torres-Espínola
Cristina CampoyCristina Campoy
Cristina Campoy

10 February 2017 in British Journal of Nutrition
Verified
Journal Article
Closed access
SBStaffan K. Berglund
Staffan K. Berglund
FTFrancisco J. Torres-Espínola
Francisco J. Torres-Espínola
LGLuz Garcia-Valdes
Luz Garcia-Valdes
MSMaria Teresa Segura
Maria Teresa Segura
CMCristina Martínez-Zaldívar
Cristina Martínez-Zaldívar
Cristina CampoyCristina Campoy
Cristina Campoy
Both maternal Fe deficiency (ID) and being overweight or obese (Ow/Ob, BMI≥25 kg/m2) may negatively affect offspring brain development. However, the two risk factors correlate and their independent effects on infant neurodevelopment are unclear. PREOBE is a prospective observational study that included 331 pregnant Spanish women, of whom 166 had pre-gestational Ow/Ob. Fe status was analysed at 34 weeks and at delivery, and babies were assessed using Bayley III scales of neurodevelopment at 18 months. In confounder-adjusted analyses, maternal ID at 34 weeks was associated with lower composite motor scores at 18 months (mean 113·3 (sd9·9)v. 117·1 (sd9·2),P=0·039). Further, the offspring of mothers with ID at delivery had lower cognitive scores (114·0 (sd9·7)v. 121·5 (sd10·9),P=0·039) and lower receptive, expressive and composite (99·5 (sd8·6)v. 107·6 (sd8·3),P=0·004) language scores. The negative associations between maternal ID at delivery and Bayley scores remained even when adjusting for maternal Ow/Ob and gestational diabetes. Similarly, maternal Ow/Ob correlated with lower gross motor scores in the offspring (12·3 (sd2·0)v. 13·0 (sd2·1),P=0·037), a correlation that remained when adjusting for maternal ID. In conclusion, maternal ID and pre-gestational Ow/Ob are both negatively associated with Bayley scores at 18 months, but independently and on different subscales. These results should be taken into account when considering Fe supplementation for pregnant women.

9 June 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
APAndrea de la Garza Puentes
Andrea de la Garza Puentes
Rosa MontesRosa Montes
Rosa Montes
ATAida Maribel Chisaguano Tonato
Aida Maribel Chisaguano Tonato
FTFrancisco José Torres-Espínola
Francisco José Torres-Espínola
MGMiriam Arias García
Miriam Arias García
PTPreobe Team
Preobe Team
Single nucleotide polymorphisms (SNPs) in the genes encoding the fatty acid desaturase (FADS) and elongase (ELOVL) enzymes affect long-chain polyunsaturated fatty acid (LC-PUFA) production. We aimed to determine if these SNPs are associated with body mass index (BMI) or affect fatty acids (FAs) in pregnant women. Participants (n = 180) from the PREOBE cohort were grouped according to pre-pregnancy BMI: normal-weight (BMI = 18.5–24.9, n = 88) and overweight/obese (BMI≥25, n = 92). Plasma samples were analyzed at 24 weeks of gestation to measure FA levels in the phospholipid fraction. Selected SNPs were genotyped (7 in FADS1, 5 in FADS2, 3 in ELOVL2 and 2 in ELOVL5). Minor allele carriers of rs174545, rs174546, rs174548 and rs174553 (FADS1), and rs1535 and rs174583 (FADS2) were nominally associated with an increased risk of having a BMI≥25. Only for the normal-weight group, minor allele carriers of rs174537, rs174545, rs174546, and rs174553 (FADS1) were negatively associated with AA:DGLA index. Normal-weight women who were minor allele carriers of FADS SNPs had lower levels of AA, AA:DGLA and AA:LA indexes, and higher levels of DGLA, compared to major homozygotes. Among minor allele carriers of FADS2 and ELOVL2 SNPs, overweight/obese women showed higher DHA:EPA index than the normal-weight group; however, they did not present higher DHA concentrations than the normal-weight women. In conclusion, minor allele carriers of FADS SNPs have an increased risk of obesity. Maternal weight changes the effect of genotype on FA levels. Only in the normal-weight group, minor allele carriers of FADS SNPs displayed reduced enzymatic activity and FA levels. This suggests that women with a BMI≥25 are less affected by FADS genetic variants in this regard. In the presence of FADS2 and ELOVL2 SNPs, overweight/obese women showed higher n-3 LC-PUFA production indexes than women with normal weight, but this was not enough to obtain a higher n-3 LC-PUFA concentration.

1 November 2016 in Trends in Food Science & Technology
Verified
Journal Article
Closed access
TCTomás Cerdó
Tomás Cerdó
LGLuz Garcia-Valdes
Luz Garcia-Valdes
SASigne Altmäe
Signe Altmäe
ARAlicia Ruíz
Alicia Ruíz
ASAntonio Suárez
Antonio Suárez
Cristina CampoyCristina Campoy
Cristina Campoy